Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo

Inhibition of Glycogen Synthase Kinase-3 in Androgen-Responsive Prostate Cancer Cell Lines: Are GSK Inhibitors Therapeutically Useful?

(2015) Ludwig Rinnab et al.   NEOPLASIA

The biology of hormone refractory breast and prostate cancer: An NCI workshop report

(2010) Suresh Mohla et al.   CANCER BIOLOGY & THERAPY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Potential Therapeutic Effect of Glycogen Synthase Kinase 3  Inhibition against Human Glioblastoma

(2009) K. Miyashita et al.   CLINICAL CANCER RESEARCH

Deregulated GSK3  Sustains Gastrointestinal Cancer Cells Survival by Modulating Human Telomerase Reverse Transcriptase and Telomerase

(2009) W. Mai et al.   CLINICAL CANCER RESEARCH

Prostate cancer — chemoprevention

(2009) Fritz H. Schröder et al.   EUROPEAN JOURNAL OF CANCER

Chemoprevention of Prostate Cancer

(2009) Ian M. Thompson et al.   JOURNAL OF UROLOGY

C/EBPα redirects androgen receptor signaling through a unique bimodal interaction

(2009) J Zhang et al.   ONCOGENE

Identification of targets of the Wnt pathway destruction complex in addition to  -catenin

(2009) N.-G. Kim et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion

(2009) William P Harris et al.   Nature clinical practice. Urology

Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy

(2008) Jia Luo   CANCER LETTERS

Unique and Overlapping Functions of GSK-3 Isoforms in Cell Differentiation and Proliferation and Cardiovascular Development

(2008) Thomas Force et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Dysregulation of the C/EBPα Differentiation Pathway in Human Cancer

(2008) Steffen Koschmieder et al.   JOURNAL OF CLINICAL ONCOLOGY